Metabolomic profiles of myocardial ischemia under treatment with salvianolic acid B

Chinese Medicine

Volumn 7, Issue , 2012, Pages

  Lu, Yonghai ^a,b   Zheng, Yue ^a,c   Liu, Xinru ^a   Liang, Xu ^a   Ngai, Saiming ^b   Li, Tiejun ^a   Zhang, Weidong ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c General Hospital of Chinese People's Liberation Army   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CAPTOPRIL; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; ISOSORBIDE DINITRATE; PROPRANOLOL; SALVIANOLIC ACID B; VERAPAMIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR DISEASE; CELL LINE; CONTROLLED STUDY; HEART MUSCLE ISCHEMIA; MALE; METABOLOMICS; NONHUMAN; RAT; SALVIA MILTIORRHIZA;

EID: 84862816119     PISSN: None     EISSN: 17498546     Source Type: Journal    
DOI: 10.1186/1749-8546-7-6     Document Type: Article

References (31)

1. World Health Organization Department of Health Statistics and Informatics in the Information, Evidence and Research Cluster. 2004, The global burden of disease 2004 update. Geneva: WHO, World Health Organization.
2. Gao Y, Gao G, Long C, Han S, Zu P, Fang L, Li J. Enhanced phosphorylation of cyclic AMP response element binding protein in the brain of mice following repetitive hypoxic exposureal. Biochem Biophys Res Commun 2006, 340:661-667. 10.1016/j.bbrc.2005.12.064, 16378594.
3. Leineweber K, Böhm M, Heusch G. Cyclic adenosine monophosphate in acute myocardial infarction with heart failure: slayer or savior?. Circulation 2006, 114:365-367. 10.1161/CIRCULATIONAHA.106.642132, 16880340.
4. Chakraborti S, Das S, Kar P, Ghosh B, Samanta K, Kolley S, Ghosh S, Roy S, Chakraborti T. Calcium signaling phenomena in heart diseases: a perspective. Mol Cell Biochem 2007, 29:l-40.
5. Lin TH, Hsieh CL. Pharmacological effects of Salvia miltiorrhiza (Danshen) on cerebral infarction. Chin Med 2010, 5:2. 10.1186/1749-8546-5-2, 2823599, 20205772.
6. Davidson P, Hancock K, Leung D, Ang E, Chang E, Thompson DR, Daly J. Traditional Chinese medicine and heart disease: what does Western medicine and nursing science know about it?. Eur J Cardiovasc Nurs 2003, 2:171-181. 10.1016/S1474-5151(03)00057-4, 14622624.
7. Editorial Committee of Pharmacopoeia of Ministry of Health P.R. China The Pharmacopoeia of People's Republic of China. 2010, Chinese Medical Science and Technology Press, Beijing, year 2010, Editorial Committee of Pharmacopoeia of Ministry of Health P.R. China.
8. Lu YH, Liu XR, Liang X, Xiang L, Zhang WD. Metabolomic strategy to study therapeutic and synergistic effects of tanshinone IIA, salvianolic acid B and ginsenoside Rb1 in myocardial ischemia rats. J Ethnopharmacol 2011, 134:45-49. 10.1016/j.jep.2010.11.048, 21130150.
9. Lam FF, Yeung JH, Cheung JH. Mechanisms of the dilator action of Danshen (Salvia miltiorrhiza) on rat isolated femoral artery. J Cardiovasc Pharmacol 2005, 46:361-368. 10.1097/01.fjc.0000175439.94906.e9, 16116343.
10. Lam FF, Yeung JH, Cheung JH, Or PM. Pharmacological evidence for calcium channel inhibition by danshen (Salvia miltiorrhiza) on rat isolated femoral artery. J Cardiovasc Pharmacol 2006, 47:139-145. 10.1097/01.fjc.0000197540.12685.ce, 16424798.
11. Kim DD, Sánchez FA, Durán RG, Kanetaka T, Durán WN. Endothelial nitric oxide synthase is a molecular vascular target for the Chinese herb Danshen in hypertension. Am J Physiol Heart Circ Physiol 2007, 292:H2131-H2137. 10.1152/ajpheart.01027.2006, 17172272.
12. Chen Y, Duan G, Xie M, Chen B, Li Y. Infrared-assisted extraction coupled with high-performance liquid chromatography for simultaneous determination of eight active compounds in Radix Salviae miltiorrhizae. J Sep Sci 2010, 33:2888-2897. 10.1002/jssc.201000234, 20730830.
13. Sun Y, Zhu H, Wang J, Liu Z, Bi J. Isolation and purification of salvianolic acid A and salvianolic acid B from Salvia miltiorrhiza by high-speed counter-current chromatography and comparison of their antioxidant activity. J Chromatogr B Analyt Technol Biomed Life Sci 2009, 877:733-737. 10.1016/j.jchromb.2009.02.013, 19237321.
14. Zhao J, Lou J, Mou Y, Li P, Wu J, Zhou L. Diterpenoid tanshinones and phenolic acids from cultured hairy roots of Salvia miltiorrhiza Bunge and their antimicrobial activities. Molecules 2011, 16:2259-2267. 10.3390/molecules16032259, 21383662.
15. Feng LX, Jing CJ, Tang KL, Tao L, Cao ZW, Wu WY, Guan SH, Jiang BH, Yang M, Liu X, Guo DA. Clarifying the signal network of salvianolic acid B using proteomic assay and bioinformatic analysis. Proteomics 2011, 11:1473-1485. 10.1002/pmic.201000482, 21365754.
16. Fu J, Huang H, Liu J, Pi R, Chen J, Liu P. Tanshinone IIA protects cardiac myocytes against oxidative stress-triggered damage and apoptosis. Eur J Pharmacol 2007, 568:213-221. 10.1016/j.ejphar.2007.04.031, 17537428.
17. He HB, Yang XZ, Shi MQ, Zeng XW, Wu LM, Li LD. Comparison of cardioprotective effects of salvianolic acid B and benazepril on large myocardial infarction in rats. Pharmacol Rep 2008, 60:369-381.
18. Wang Z, Li M, Wu WK, Tan HM, Geng DF. Ginsenoside Rb1 preconditioning protects against myocardial infarction after regional ischemia and reperfusion by activation of phosphatidylinositol-3-kinase signal transduction. Cardiovasc Drugs Ther 2008, 22:443-452. 10.1007/s10557-008-6129-4, 18679782.
19. Xu W, Yang J, Wu LM. Cardioprotective effects of tanshinone IIA on myocardial ischemia injury in rats. Pharmazie 2009, 64:332-336.
20. Yang FG, Zhang AY, Chen ZY, Lian ZX, Liu GX, Dong GX. Effects of salvianolic acid B on cardiovascular endothelial cells and platelet activation in a rabbit model of ischemia-reperfusion. Zhong Xi Yi Jie He Xue Bao 2008, 6:1250-1254. 10.3736/jcim20081208, 19063838.
21. Nicholson JK, Lindon JC, Holmes E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999, 29:1181-1118. 10.1080/004982599238047, 10598751.
22. Slupsky CM, Steed H, Wells TH, Dabbs K, Schepansky A, Capstick V, Faught W, Sawyer MB. Urine metabolite analysis offers potential early diagnosis of ovarian and breast cancers. Clin Cancer Res 2010, 16:5835-5841. 10.1158/1078-0432.CCR-10-1434, 20956617.
23. Verhoeckx KC, Bijlsma S, Jespersen S, Ramaker R, Verheij ER, Witkamp RF, van der Greef J, Rodenburg RJ. Characterization of anti-inflammatory compounds using transcriptomics, proteomics, and metabolomics in combination with multivariate data analysis. Int Immunopharmacol 2004, 4:1499-1514. 10.1016/j.intimp.2004.07.008, 15351319.
24. Ytrehus K. Models of myocardial ischemia. Drug Discov Today Dis Models 2006, 3:263-271.
25. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65:55-63. 10.1016/0022-1759(83)90303-4, 6606682.
26. Bradley KN, Craig JW, Muir TC, McCarron JG. The sarcoplasmic reticulum and sarcolemma together form a passive Ca2+ trap in colonic smooth muscle. Cell Calcium 2004, 36:29-41. 10.1016/j.ceca.2003.11.008, 15126054.
27. Kumar M, Hsiao K, Vidugiriene J, Goueli SA. A bioluminescent-based, HTS-compatible assay to monitor G-protein-coupled receptor modulation of cellular cyclic AMP. Assay Drug Dev Technol 2007, 5:237-245. 10.1089/adt.2006.055, 17477832.
28. Saudohar M, Bencina M, van de Vondervoort PJ, Panneman H, Legisa M, Visser J, Ruijter GJ. Cyclic AMP-dependent protein kinase is involved in morphogenesis of Aspergillus niger. Microbiology 2002, 148:2635-2645.
29. Lv YH, Liu XR, Yan SK, Liang X, Yang Y, Dai WX, Zhang WD. Metabolomic study of myocardial ischemia and intervention effects of Compound Danshen Tablets in rats using ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry. J Pharm Biomed Anal 2010, 52:129-135. 10.1016/j.jpba.2009.12.016, 20079594.
30. Kimes BW, Brandt BL. Properties of a clonal muscle cell line from rat heart. Exp Cell Res 1976, 98:367-381. 10.1016/0014-4827(76)90447-X, 943302.
31. Zhou L, Ma W, Yang Z, Zhang F, Lu L, Ding Z, Ding B, Ha T, Gao X, Li C. VEGF165 and angiopoietin-1 decreased myocardium infarct size through phosphatidylinositol-3 kinase and Bcl-2 pathways. Gene Ther 2005, 12:196-202. 10.1038/sj.gt.3302416, 15510173.